FIBROSIS PROGRESSION IN NON RESPONDERS TO ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION (LT)

被引：0

作者：

De Martin, E. ^{[1
]}

Senzolo, M. ^{[1
]}

Ponziani, F. R. ^{[2
]}

Pasulo, L. ^{[12
]}

Gasbarrini, A. ^{[2
]}

Vigano, R. ^{[3
]}

Belli, L. ^{[3
]}

Donato, F. ^{[4
]}

Angelico, M. ^{[5
]}

Di Paolo, D. ^{[5
]}

Rendina, M. ^{[6
]}

Miglioresi, L. ^{[7
]}

Grazi, G. ^{[8
]}

Morelli, M. C. ^{[8
]}

Toniutto, P. ^{[9
]}

Merli, M. ^{[10
]}

Jemmolo, M. ^{[11
]}

Gerunda, G. E. ^{[11
]}

Fagiuoli, S. ^{[12
]}

Burra, P. ^{[1
]}

机构：

[1] Univ Padua Polyclin, Padua, Italy

[2] Policlin Gemelli, Rome, Italy

[3] Osped Niguarda Ca Granda, Milan, Italy

[4] Policlin Univ, Milan, Italy

[5] Policlin Torvergata, Rome, Italy

[6] Ospedale Univ, Bari, Italy

[7] S Camillo Forlanini, Rome, Italy

[8] Policlin Univ, Bologna, Italy

[9] Osped Univ, Udine, Italy

[10] Policlin Umberto 1, Rome, Italy

[11] Policlin Univ, Modena, Italy

[12] Osped Riuniti Bergamo, Bergamo, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2010年 / 42卷

关键词：

D O I：

10.1016/S1590-8658(10)60454-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

T.N.49

引用

页码：S32 / S32

页数：1

共 50 条

[41] SURVIVAL AND PROGRESSION OF FIBROSIS IN HISPANIC AND NON-HISPANIC LIVER TRANSPLANT (LT) RECIPIENTS WITH HEPATITIS C (HCV)
Verna, Elizabeth C.
Valadao, Rosa M.
Farrand, Erica
Pichardo, Elsa
Lai, Jennifer C.
Terrault, Norah
Brown, Robert S.
HEPATOLOGY, 2009, 50 (04) : 550A - 550A
[42] THE EFFECT OF HCV ANTIVIRAL THERAPY ON FIBROSIS PROGRESSION
Lu, M.
Li, J.
Rupp, L. B.
Holmberg, S. D.
Moorman, A. C.
Spradling, P. R.
Tehale, E.
Xu, F.
Boscarino, J. A.
Vijayadeva, V.
Schmidt, M. A.
Lamerato, L. E.
Gordon, S.
JOURNAL OF HEPATOLOGY, 2015, 62 : S622 - S622
[43] MicroRNA Signature at the Time of Clinical HCV Recurrence Associates With Aggressive Fibrosis Progression Post-Liver Transplantation
Gehrau, R. C.
Mas, V. R.
Villamil, F. G.
Dumur, C. I.
Mehta, N. K.
Suh, J. L.
Maluf, D. G.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (03) : 729 - 737
[44] Fibrosis Progression and the Pros and Cons of Antiviral Therapy for Hepatitis C Virus Recurrence After Liver Transplantation: A Review
De Martin, E.
Senzolo, M.
Gambato, M.
Germani, G.
Vitale, A.
Russo, F. R.
Burra, P.
TRANSPLANTATION PROCEEDINGS, 2010, 42 (06) : 2223 - 2225
[45] HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients
Duclos-Vallee, JC
Vittecoq, D
Teicher, E
Feray, C
Roque-Afonso, AM
Lombes, A
Jardel, C
Gigou, M
Dussaix, E
Guettier, C
Sebagh, M
Azoulay, D
Adam, R
Ichai, P
Saliba, F
Roche, B
Castaing, D
Samuel, D
JOURNAL OF HEPATOLOGY, 2004, 40 : 44 - 44
[46] Rate of Fibrosis Progression Following Liver Transplantation in NASH
Sourianarayanane, A.
Arikapudi, S.
McCullough, A.
Humar, A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 705 - 705
[47] Recurrent hepatitis C virus (HCV), fibrosis progression following liver transplantation: Impact of donor steatosis
Botha, JF
Thompson, E
Gilroy, R
Grant, W
Sudan, D
Shaw, B
Langnas, A
LIVER TRANSPLANTATION, 2006, 12 (05) : C114 - C114
[48] Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients
Labarga, Pablo
Fernandez-Montero, Jose V.
de Mendoza, Carmen
Barreiro, Pablo
Pinilla, Javier
Soriano, Vincent
ANTIVIRAL THERAPY, 2015, 20 (03) : 329 - 334
[49] Treatment of HCV prior to liver transplantation to prevent HCV recurrence - Wise or wasteful?
Gallegos-Orozco, Juan F.
Charlton, Michael R.
LIVER INTERNATIONAL, 2015, 35 (01) : 9 - 11
[50] Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation
Heydtmann, M
Freshwater, D
Dudley, T
Lai, V
Palmer, S
Hübscher, S
Mutimer, D
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (04) : 825 - 833

← 1 2 3 4 5 →